Andrew Ip

16PUBLICATIONS
101CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Disease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Oct 01, 2026
Efficacy and safety of tirabrutinib monotherapy for relapsed/refractory primary CNS lymphoma: PROSPECT phase 2 trial.

|Sep 18, 2026
TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

|Aug 13, 2026
Using cell-free RNA to identify B- and T-cell clonality for diagnosis and monitoring of B- and T-cell neoplasms.

|Feb 24, 2026
Real-world outcomes after CAR T versus standard therapy in third-line or later relapsed or refractory follicular lymphoma in the United States.

Philip K Chan, Markqayne Ray, Karl M Kilgore

|Nov 14, 2025
Correlates and Detection of Digital Health Literacy in Patients With Colorectal Carcinoma or Non-Hodgkin Lymphoma: Cross-Sectional Study.

Thomas S Gunning, Amanda Khoudary, Osairys Billini

|Jul 01, 2025
Outcomes of CD19 CAR-T therapy in central nervous system lymphoma: Insights from a multicentre experience.

Giulio Cassanello, Efrat Luttwak, Samantha Brown

Pageof 3

Frequent Collaborators

3 joint publications

Miguel-Angel Perales

3 joint publications

Roni Shouval

2 joint publications

Stuart L Goldberg

2 joint publications

Richard J Lin